COMMONWEALTH BIOTECHNOLOGIES INC
8-K, 1998-05-08
COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Previous: ATLAS ENERGY FOR THE NINETIES PUBLIC NO 6 LTD, 10QSB, 1998-05-08
Next: AMERICAN SKIING CO /ME, 8-K, 1998-05-08




                                 UNITED STATES

                       SECURITIES AND EXCHANGE COMMISSION

                             WASHINGTON, D.C. 20549


                                 --------------


                                    FORM 8-K

                                 CURRENT REPORT
                    PURSUANT TO SECTION 13 OR 15 (d) OF THE
                        SECURITIES EXCHANGE ACT OF 1934


Date of report (Date of earliest event reported)  May 7, 1998

                       COMMONWEALTH BIOTECHNOLOGIES, INC.
               (Exact Name of Registrant as Specified in Charter)

         Virginia                      001-13467              56-1641133
(State or Other Jurisdiction    (Commission File Number)   (IRS Employer
 of Incorporation)                                           Identification No.)


         911 East Leigh Street, Suite G-19, Richmond, Virginia        23219
                    (Address of Principal Executive Offices)        (Zip Code)


Registrant's telephone number, including area code:  (804) 648-3820



                                      N/A
         (Former Name or Former Address, if Changed Since Last Report)




<PAGE>


Item 5.  Other Events.

         On May 7, 1998, the Registrant announced the appointment of former
Virginia Governor George Allen to its Board of Directors. A copy of the press
release relating to the announcement is attached as an exhibit hereto.

Item 7.  Financial Statements and Exhibits.

         (a)      Financial Statements of Businesses Acquired.

                           Not applicable.

         (b)      Pro Forma Financial Information.

                           Not applicable.

         (c)      Exhibits.

                  99.1     Press Release, dated May 7, 1998, announcing the
                           appointment of former Virginia Governor George Allen
                           to the Registrant's Board of Directors.





<PAGE>


                                   SIGNATURES

         Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.


                                        COMMONWEALTH BIOTECHNOLOGIES, INC.



                                        By:     /s/ Robert B. Harris, Ph.D.
                                                 --------------------------
                                                 Robert B. Harris, Ph.D.
                                                 President







May 8, 1998

<PAGE>






                                 EXHIBIT INDEX


Number            Description of Exhibit
- ------            ----------------------

99.1              Press Release, dated May 7, 1998, announcing the appointment
                  of former Virginia Governor George Allen to the Registrant's
                  Board of Directors.







             Former Governor George Allen Joins Board of Directors
                     For Commonwealth Biotechnologies, Inc.



RICHMOND, Va. - Commonwealth Biotechnologies, Inc. (CBI), announced today that
former Virginia Governor George Allen is the newest member of the Company's
board of directors. Allen's appointment was announced today during the
groundbreaking ceremony for CBI's future headquarters at Gateway Centre in
Chesterfield County.

As Virginia's 67th Governor, Allen prioritized economic development and job
creation. His administration generated $14 billion in new investments and
300,000 net new private sector jobs for the Commonwealth during his term in
office from 1994 to 1998.

"CBI is an  inspiring  success  story of a small group of  enterprising
scientists  becoming one of the leaders of biotechnology  in  Virginia,"  said
Allen.  "Their  growth is a testament to all the hard work of its existing team
and visionary  leadership of its four founding  partners:  Dr. Richard J. Freer,
Dr. Robert B. Harris,  Dr. Gregory A. Buck and  Thomas R.  Reynolds.  It will be
a pleasure  to join the board of this  creative,  innovative  company which will
continue to grow and serve the people and companies throughout the U.S. and
around the world."

CBI's new $4 million,  32,000  square-foot  corporate office and laboratory
complex will allow CBI to add 15 to 20 people to its current staff of 40 over
the next 12-18 months.

CBI received the 1998 Greater Richmond Technology Council Award in the Emerging
Technology category.

CBI was founded in 1992 and provides research and development services to more
than 400 private, government and academic customers in the global biotechnology
industry. Since then, CBI has grown from a single employee to a staff of 40
employees, including 7 doctoral scientists who direct research in bioorganic
chemistry, biochemistry, molecular biology, genetic testing, immunochemistry and
related areas.

CBI's revenues have grown from approximately $300,000 in 1993, to $1.761 million
in 1997. The company became public in October 1997, and has 1,620,514 shares
outstanding.





© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission